<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR185">
 <label>185.</label>
 <mixed-citation publication-type="other">Sofen, Howard, et al. Guselkumab (an IL-23–specific mAb) demonstrates clinical and molecular response in patients with moderate-to-severe psoriasis. J Allergy Clin Immunol. 2014;133(4):1032–40.</mixed-citation>
</ref>
